GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biosyent Inc (TSXV:RX) » Definitions » Balance Sheet Cash And Cash Equivalents

Biosyent (TSXV:RX) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 1979. Start your Free Trial

What is Biosyent Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


Biosyent Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biosyent Inc (TSXV:RX) » Definitions » Balance Sheet Cash And Cash Equivalents
Traded in Other Exchanges
Address
2476 Argentia Road, Suite 402, Toronto, Mississauga, ON, CAN, L5N 6M1
Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.
Executives
Peter Douglas Lockhard Director
Blair Driscoll 10% Security Holder
Merrilyn Joy Driscoll 10% Security Holder
Sean Driscoll 10% Security Holder
Fax Capital Corp. 10% Security Holder
Fax Investments Inc. 10% Security Holder
Federated Capital Corp. 10% Security Holder
Seyed Ahmad Ashrafi Director
Robert Joseph March Senior Officer
Sharan Raghubir Senior Officer
Rene Goehrum 10% Security Holder, Director, Senior Officer
Biosyent Inc. Issuer
Joost Van Der Mark Senior Officer
Sara Elford Director
Alfred D'souza Director